Moreover, the MCB1‐overexpressing hepatoma cells were resistant to CDDP, sorafenib or lenvatinib in comparison with the control cells, which was demonstrated by a higher inhibitive concentration (Figure S6D, Supporting Information). Here, PSMD4 is linked to hepatocellular carcinoma.